260 related articles for article (PubMed ID: 18820579)
41. Are we ready for pandemic influenza H5N1?
Stephenson I
Expert Rev Vaccines; 2005 Apr; 4(2):151-5. PubMed ID: 15889987
[TBL] [Abstract][Full Text] [Related]
42. Predictability and preparedness in influenza control.
Smith DJ
Science; 2006 Apr; 312(5772):392-4. PubMed ID: 16627736
[TBL] [Abstract][Full Text] [Related]
43. [The use of anti-viral agents in pandemic influenza, Icelandic guidelines].
Gudnason T; Sigmundsdottir G; Briem H
Laeknabladid; 2008 Jan; 94(1):19-25. PubMed ID: 18204108
[TBL] [Abstract][Full Text] [Related]
44. Origins and Evolutionary Dynamics of H3N2 Canine Influenza Virus.
Zhu H; Hughes J; Murcia PR
J Virol; 2015 May; 89(10):5406-18. PubMed ID: 25740996
[TBL] [Abstract][Full Text] [Related]
45. Vaccine production capacity for seasonal and pandemic (H1N1) 2009 influenza.
Collin N; de Radiguès X;
Vaccine; 2009 Aug; 27(38):5184-6. PubMed ID: 19563891
[TBL] [Abstract][Full Text] [Related]
46. Epidemiology of H5N1 avian influenza.
Yee KS; Carpenter TE; Cardona CJ
Comp Immunol Microbiol Infect Dis; 2009 Jul; 32(4):325-40. PubMed ID: 18448168
[TBL] [Abstract][Full Text] [Related]
47. Pandemic influenza: is there a corporate duty to prepare?
McMenamin JP
Food Drug Law J; 2009; 64(1):69-100. PubMed ID: 19998573
[TBL] [Abstract][Full Text] [Related]
48. Use of neuraminidase inhibitors to combat pandemic influenza.
Democratis J; Pareek M; Stephenson I
J Antimicrob Chemother; 2006 Nov; 58(5):911-5. PubMed ID: 16956904
[TBL] [Abstract][Full Text] [Related]
49. Pandemics, avian influenza A (H5N1), and a strategy for pharmacists.
Ford SM; Grabenstein JD
Pharmacotherapy; 2006 Mar; 26(3):312-22. PubMed ID: 16503711
[TBL] [Abstract][Full Text] [Related]
50. Influenza virus hemagglutinin--structural studies and their implications for the development of therapeutic approaches.
Stevens J; Donis RO
Infect Disord Drug Targets; 2007 Dec; 7(4):329-35. PubMed ID: 18220964
[TBL] [Abstract][Full Text] [Related]
51. Aflunov(®): a prepandemic influenza vaccine.
Gasparini R; Amicizia D; Lai PL; Panatto D
Expert Rev Vaccines; 2012 Feb; 11(2):145-57. PubMed ID: 22309663
[TBL] [Abstract][Full Text] [Related]
52. Bird flu redux.
Barie PS
Surg Infect (Larchmt); 2005; 6(4):367-8. PubMed ID: 16433600
[No Abstract] [Full Text] [Related]
53. Modeling the worldwide spread of pandemic influenza: baseline case and containment interventions.
Colizza V; Barrat A; Barthelemy M; Valleron AJ; Vespignani A
PLoS Med; 2007 Jan; 4(1):e13. PubMed ID: 17253899
[TBL] [Abstract][Full Text] [Related]
54. Avian influenza and the failure of public rationing discussions.
DeCoster B
J Law Med Ethics; 2006; 34(3):620-3. PubMed ID: 17144186
[No Abstract] [Full Text] [Related]
55. Antiviral drugs for the control of pandemic influenza virus.
Sugrue RJ; Tan BH; Yeo DS; Sutejo R
Ann Acad Med Singap; 2008 Jun; 37(6):518-24. PubMed ID: 18618065
[TBL] [Abstract][Full Text] [Related]
56. Influenza is now a preventable disease.
Oxford JS; Lambkin R
Int J Antimicrob Agents; 2006 Apr; 27(4):271-3. PubMed ID: 16564681
[TBL] [Abstract][Full Text] [Related]
57. Fortune favours the prepared mind: a national perspective on pandemic preparedness.
Tam T; Sciberras J; Mullington B; King A
Can J Public Health; 2005; 96(6):406-8. PubMed ID: 16350861
[TBL] [Abstract][Full Text] [Related]
58. Pandemic influenza--including a risk assessment of H5N1.
Taubenberger JK; Morens DM
Rev Sci Tech; 2009 Apr; 28(1):187-202. PubMed ID: 19618626
[TBL] [Abstract][Full Text] [Related]
59. H5N1 influenza pandemic: contingency plans.
Tsang KW; Eng P; Liam CK; Shim YS; Lam WK
Lancet; 2005 Aug 13-19; 366(9485):533-4. PubMed ID: 16099278
[No Abstract] [Full Text] [Related]
60. Meeting review: options for the control of influenza VI.
Kaminski DA
Viral Immunol; 2007 Dec; 20(4):525-30. PubMed ID: 18158726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
